How Tachykinin Peptides Control Reproductive Hormone Release and Fertility

Tachykinin peptides (neurokinin A, neurokinin B, and substance P) play essential roles in controlling GnRH release, puberty timing, and the ovulatory cycle.

Leon, Silvia et al.·Seminars in reproductive medicine·2019·
RPEP-043172019RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Tachykinins (NKA, NKB, and substance P) participate in the central control of GnRH release through neuronal circuits that activate Kiss1 neurons and synchronize their activity within the arcuate nucleus. Their roles extend across the full spectrum of reproductive function: regulating the pulsatile pattern of GnRH release, determining the timing of puberty onset, and controlling the preovulatory LH surge in females. The review synthesizes evidence that tachykinins are critical for all major aspects of fertility attainment and maintenance.

Key Numbers

How They Did This

This is a narrative review article summarizing recent advances in understanding tachykinin biology in reproductive neuroendocrinology, drawing from both animal studies and human data.

Why This Research Matters

Understanding how tachykinins regulate fertility opens doors for new treatments for reproductive disorders. Neurokinin B is already a drug target — NK3 receptor antagonists are being developed for conditions like polycystic ovary syndrome and endometriosis. Deeper knowledge of the full tachykinin system could yield additional therapeutic opportunities.

The Bigger Picture

The discovery of kisspeptin-neurokinin B-dynorphin (KNDy) neurons revolutionized reproductive neuroendocrinology. This review places tachykinins within that broader framework, highlighting how peptide-based signaling networks coordinate the precise hormonal patterns needed for fertility — an area now translating into novel drugs for reproductive health conditions.

What This Study Doesn't Tell Us

As a review article, this paper synthesizes existing research rather than presenting new data. The authors note existing controversies and open questions in the field, including unresolved aspects of how individual tachykinins interact within the reproductive circuits.

Questions This Raises

  • ?Can targeting specific tachykinin receptors provide new treatments for infertility or precocious puberty?
  • ?How do the three tachykinins interact with each other and with kisspeptin within the KNDy neuron system?
  • ?Could tachykinin-based therapies offer advantages over current GnRH-based treatments for reproductive disorders?

Trust & Context

Key Stat:
3 critical roles in fertility Tachykinins regulate GnRH pulsatility, puberty timing, and the preovulatory LH surge — all essential for reproductive success
Evidence Grade:
This is a narrative review synthesizing evidence from multiple studies. While it provides a comprehensive overview of the field, it does not include a systematic methodology or meta-analysis, and the strength of individual findings varies.
Study Age:
Published in 2019, this review captures the state of knowledge during a period of rapid discovery in reproductive neuropeptide biology. The field has continued to advance since publication.
Original Title:
Novel Biology of Tachykinins in Gonadotropin-Releasing Hormone Secretion.
Published In:
Seminars in reproductive medicine, 37(3), 109-118 (2019)
Database ID:
RPEP-04317

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What are tachykinins and where are they found?

Tachykinins are a family of small peptides found in the brain and nervous system. The three main members — neurokinin A, neurokinin B, and substance P — act as chemical messengers between neurons. In the context of reproduction, they're concentrated in a brain region called the arcuate nucleus where they help control fertility hormones.

Are there already drugs targeting tachykinins for reproductive health?

Yes, drugs that block the NK3 receptor (which responds to neurokinin B) are being developed and tested in clinical trials for conditions like polycystic ovary syndrome, endometriosis, and hot flashes in menopause. Understanding the full tachykinin system may lead to additional therapeutic options.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-04317·https://rethinkpeptides.com/research/RPEP-04317

APA

Leon, Silvia; Navarro, Víctor M. (2019). Novel Biology of Tachykinins in Gonadotropin-Releasing Hormone Secretion.. Seminars in reproductive medicine, 37(3), 109-118. https://doi.org/10.1055/s-0039-3400252

MLA

Leon, Silvia, et al. "Novel Biology of Tachykinins in Gonadotropin-Releasing Hormone Secretion.." Seminars in reproductive medicine, 2019. https://doi.org/10.1055/s-0039-3400252

RethinkPeptides

RethinkPeptides Research Database. "Novel Biology of Tachykinins in Gonadotropin-Releasing Hormo..." RPEP-04317. Retrieved from https://rethinkpeptides.com/research/leon-2019-novel-biology-of-tachykinins

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.